logo
15:59 Dec 05

Senores Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
776.75
-9.75 (-1.24%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Senores Pharmaceuticals Ltd. Financials

Senores Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
776.75
-9.75 (-1.24%)
15:59 Dec 05
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

32/100
Mid Valuation

Technical

62/100
Technically Moderately Bullish

Strength

14

Weakness

7

Opportunity

1

Threats

0

7.44 %

ROE %

4.77 %

ROA %

18.92

EPS

170.73

BVPS

14.70 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
14.17 35.34 214.52 398.25 535.43
Operating Expenses +
12.23 22.66 172.93 308.55 411.78
Raw Material
10.43 13.24 102.26 181.46 238.03
Increase Decrease in Cost
-2.4 -0.48 3.88 -0.76 3.69
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2.86 4.79 35.46 60.37 81.89
Miscellaneous Expenses
22.2 30.91 171.93 247.12 88.17
Operating Profit
1.94 12.68 41.59 89.7 123.65
Other Income
0.46 3.68 2.82 19.26 22.62
Depreciation
0.7 1.78 10.02 16.84 22.8
Interest
0.56 2.14 9.45 21.55 26.54
Profit before tax and exceptio..
1.14 12.44 24.94 70.57 96.93
Exceptional Items
0 0 0 0 0
PBT
1.14 12.44 24.94 70.57 96.93
Provision for Taxation
0.15 4 -7.76 12.23 17.51
Net Profit
0.99 8.43 32.71 58.34 79.41
NET Profit after MI
0.99 8.43 31.46 58.56 78.18
EPS
1.81 8.87 12.21 16.12 20.61
Operating Profit Margin (%)
13.69 35.88 19.39 22.52 23.09
Net Profit Margin (%)
6.99 23.85 14.67 14.7 14.6

Senores Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 45.80 45.80 45.80 45.80
FII 4.30 3.70 4.20 4.20
Public 8.60 9.50 9.60 11.80
Others 41.30 41.00 40.40 38.20
Shareholder Shares Holding %
Research 360 logo
Download Our App On: